MIR145 Core Promoter Methylation in Pretreatment Cell-Free DNA: A Liquid Biopsy Tool for Muscle-Invasive Bladder Cancer Treatment Outcome.

Katerina-Marina Pilala Georgios Kotronopoulos Panagiotis LevisGeorgios-Christos GiagkosKonstantinos StravodimosDido VassilacopoulouAndreas Scorilas Margaritis Avgeris

Published in: JCO precision oncology (2024)

core promoter in pretreatment cfDNA could serve as a minimally invasive and independent predictor of MIBC treatment outcome and emerge as a promising marker for blood-based test in BlCa.

Keyphrases

muscle invasive bladder cancer
dna methylation
minimally invasive
transcription factor
gene expression
cell proliferation
genome wide
long non coding rna
long noncoding rna
ultrasound guided
ionic liquid
fine needle aspiration
robot assisted